CD4 + Target Cell Availability Determines the Dynamics of Immune Escape and Reversion In Vivo
- 15 April 2008
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 82 (8) , 4091-4101
- https://doi.org/10.1128/jvi.02552-07
Abstract
Infections with human immunodeficiency virus (HIV) and the closely related monkey viruses simian-human immunodeficiency virus (SHIV) and simian immunodeficiency virus (SIV) are characterized by progressive waves of immune responses, followed by viral mutation and “immune escape.” However, escape mutation usually leads to lower replicative fitness, and in the absence of immune pressure, an escape mutant (EM) virus “reverts” to the wild-type phenotype. Analysis of the dynamics of immune escape and reversion has suggested it is a mechanism for identifying the immunogens best capable of controlling viremia. We have analyzed and modeled data of the dynamics of wild-type (WT) and EM viruses during SHIV infection of macaques. Modeling suggests that the dynamics of reversion and immune escape should be determined by the availability of target cells for infection. Consistent with this suggestion, we find that the rate of reversion of cytotoxic T-lymphocyte (CTL) EM virus strongly correlates with the number of CD4 + T cells available for infection. This phenomenon also affects the rate of immune escape, since this rate is determined by the balance of CTL killing and the WT fitness advantage. This analysis predicts that the optimal timing for the selection of immune escape variants will be immediately after the peak of viremia and that the development of escape variants at later times will lead to slower selection. This has important implications for comparative studies of immune escape and reversion in different infections and for identifying epitopes with high fitness cost for use as vaccine targets.Keywords
This publication has 41 references indexed in Scilit:
- Estimating the Effectiveness of Simian Immunodeficiency Virus-Specific CD8+T Cells from the Dynamics of Viral Immune EscapeJournal of Virology, 2007
- Estimating the Infectivity of CCR5-Tropic Simian Immunodeficiency Virus SIV mac251 in the GutJournal of Virology, 2007
- Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1PLoS Pathogens, 2007
- Effective T-Cell Responses Select Human Immunodeficiency Virus Mutants and Slow Disease ProgressionJournal of Virology, 2007
- In Vivo Fitness Costs of Different Gag CD8 T-Cell Escape Mutant Simian-Human Immunodeficiency Viruses for MacaquesJournal of Virology, 2007
- Vaccine-Induced T Cells Control Reversion of AIDS Virus Immune Escape MutantsJournal of Virology, 2007
- In vivoCD8+T cell control of immunodeficiency virus infection in humans and macaquesProceedings of the National Academy of Sciences, 2007
- Comparative Efficacy of Subtype AE Simian-Human Immunodeficiency Virus Priming and Boosting Vaccines in Pigtail MacaquesJournal of Virology, 2007
- Passive Sexual Transmission of Human Immunodeficiency Virus Type 1 Variants and Adaptation in New HostsJournal of Virology, 2006
- Estimating Costs and Benefits of CTL Escape Mutations in SIV/HIV InfectionPLoS Computational Biology, 2006